MEDX Ventures Group

MEDX Ventures Group is a Hingham, Massachusetts-based investment and management company founded in 2010 by Harel, who serves as CEO and Company Group Chairman, with offices in the US, Europe, and Israel. The firm focuses on Israeli medical technology and robotic companies, applying a proprietary 'X Model' that provides active management through dedicated Development, Regulatory, Commercial, and Finance teams embedded alongside portfolio companies throughout their lifecycle. In 2015, MEDX raised $30 million for Israeli biomed startups and established MEDX Xelerator, a leading medical-device-focused incubator operating under the auspices of the Israel Innovation Authority. MEDX Xelerator is located in Or Yehuda and Sakhnin, Israel, and partners with Boston Scientific, Sheba Medical Center, Intellectual Ventures, Consensus Business Group, West Pharmaceuticals, Wolfson Hospital, Weill Cornell Medicine Enterprise Innovation, and Ichilov Hospital. Innovation areas include vascular, interventional cardiology, urology, interventional oncology, medical robotics, and digital health solutions. MEDX leads rounds and invests at pre-seed through Series A stages. Across approximately 8 investments, the portfolio includes Microbot Medical (IPO), XACT Robotics (Harel serves as Chairman), Append Medical ($7.4 million Series A), and VeinWay (most recent seed investment, March 2023). The related Edge Medical Ventures launched a $70 million medtech fund to complement MEDX's earlier-stage activity. The MEDX model differs from conventional medtech VCs in that its team actively manages regulatory strategy, commercial development, and financing alongside founders rather than providing capital and periodic board oversight. This hands-on operational approach is designed to reduce time-to-market and de-risk regulatory submissions for hardware-intensive medical devices and robotic surgical systems.